Longitudinal Changes in Anatomic Biomarkers on Optical Coherence Tomography Angiography in Diabetic Retinopathy

糖尿病视网膜病变光学相干断层扫描血管造影中解剖生物标志物的纵向变化

阅读:1

Abstract

PURPOSE: To identify optical coherence tomography angiography (OCTA)-derived biomarkers correlating with diabetic retinopathy (DR) severity and characterize longitudinal retinal microvascular changes across DR stages. METHODS: In this 3-year prospective study, we analyzed OCTA images from 328 eyes of 164 adults with type II diabetes and 33 eyes from 17 healthy controls. Patients were categorized as no DR, mild, moderate, or severe nonproliferative DR (NPDR), or proliferative DR (PDR) at baseline. Bilateral OCTA scans were obtained at each visit and processed with a validated pipeline to extract seven microvascular indices from the superficial and deep capillary plexuses: vessel density, skeleton density, acircularity index, average vessel caliber, foveal avascular zone (FAZ) area, FAZ perimeter, and fractal dimensions. Linear regression quantified changes over time, and intergroup comparisons were made using ANOVA and post-hoc testing. RESULTS: Patients with severe NPDR showed a significant annual decrease in vessel density and skeleton density in the deep capillary plexus compared to healthy controls, indicating progressive ischemia. Acircularity index increased significantly in severe NPDR compared to mild NPDR, suggesting worsening macular ischemia. In the superficial plexus, severe NPDR patients exhibited significantly greater annual vessel caliber narrowing than mild NPDR. Conversely, skeleton density in PDR increased relative to severe NPDR, possibly reflecting neovascular remodeling. CONCLUSIONS: Longitudinal OCTA analysis reveals stage-specific microvascular changes in DR. These dynamic biomarkers may provide early indicators of DR progression and offer a quantitative foundation for individualized monitoring and timely intervention strategies. TRANSLATIONAL RELEVANCE: OCTA-derived biomarkers offer a noninvasive tool for detecting early DR changes and guiding personalized care strategies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。